A new drug against stroke

Became the first new drug to reduce the risk of stroke in patients who suffer from irregular heartbeat available at pharmacies in England for the first time since more than 50 years.Reached clinical testing to the drug Bradhaksa Pradaxa reduced the risk of stroke overwhelmingly by more than 33 percent among elderly people with atrial arterial compared with conventional therapy. Perhaps more importantly, that taking the new drug which reduces the intensity of the blood is much easier because it does not impose on the patient who takes that watching what eat and drink as in the case of other medication and Rfarin Warfarin.As a result of lower costs of monitoring the public health service institutions in Britain hopes manufacturers that property Bradhaksa will provide in expenses also well saved thousands of lives every year between 1.2 million people living with atrial arterial in Britain. The new drug costs 2.52 pounds per day, but institution legalize drugs in Britain asked for more information on what would be provided before expenses recommendation circulate in the health service.The Daily Telegraph quoted Professor John Kam, head of heart disease and blood vessels in the St George's Hospital in London, said the first time in which the patient discovers he suffered atrial arterial be, in many cases, after suffering a stroke, and this is a real disaster. Professor cam considered to provide an anti-clotting drug like Bradhaksa will be very important for these patients. In the meantime issued a European Medicines Agency approval of the new drug and became a family doctor can be described to the patient from 5 September 2011.

-->